Tag Archives: Research

American Legion Lobbies Trump to Reclassify Marijuana

American Legion Lobbies Trump to Reclassify Marijuana

American Legion Lobbies Trump to Reclassify Marijuana

One of the largest veteran services organizations in the United States is making a push to change marijuana’s status as a Schedule I substance.

Aclara Research - preliminary results

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study

CHICAGO, Ill., May 23, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study – the first of Illinois patients since the inception of the pilot program in 2012.

Washingtonians: WSU Needs Volunteers for Marijuana Breathalyzer Study

Washingtonians: WSU Needs Volunteers for Marijuana Breathalyzer Study

Researchers with Washington State University are looking for individuals to volunteer for a marijuana breathalyzer study. According to The Spokesman-Review, the study is attempting to determine if a marijuana breathalyzer can actually register “acute exposure” to THC.

This New Study Should Encourage Marijuana Stock Investors

This New Study Should Encourage Marijuana Stock Investors

The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.

dna brands

DNA Brands to Enter the Exploding Medical Marijuana/ CBD/ Industrial Hemp Markets

FT. LAUDERDALE, Fla., May 15, 2017 /Weed Wire/ — DNA Brands Inc. (OTC PINK: DNAX) is pleased to announce today that it will be pursuing the CBD/MMJ/ Industrial Hemp marketplace after CEO Adrian McKenzie recently returned from Colorado

SAQ

Tilray Unveils New Product Categorization System in Canada

NANAIMO, British Columbia, May 15, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada.

CBA Five years SAM Cannabis Business Alliance CBA

Cannabis Business Alliance (CBA) Lauds Colorado General Assembly for a Successful 2017 Legislative Session

DENVER, May 12, 2017 /Weed Wire/ — As the 2017 General Assembly Session comes to a close, the Cannabis Business Alliance (CBA) applauds legislators for another productive session in regards to the continued regulation of the legal cannabis industry in Colorado.

Alternate Health Corp - zika

Alternate Health Corp Reports Full Year 2016 Financial Results

DALLAS, Texas, May 8, 2017 /Weed Wire/ – Alternate Health Corp. (CSE: AHG and OTC: AHGIF), a diverse healthcare company that uses its expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry, today announced its results for the full year ending December 31, 2016.

Health Research Chair on Cannabis Established at STU

FREDERICTON, New Brunswick, May 5, 2017 /Weed Wire/ — Premier Brian Gallant joined representatives from STU, Shoppers Drug Mart and the New Brunswick Health Research Foundation to announce the establishment of a health research chair on cannabis at the university.

ebbu water soluble

ebbu™ Unveils Patent Pending Water Soluble “Aqua Drops”

EVERGREEN, Colo., April 25, 2017 /Weed Wire/ — ebbu™, an industry leader in cannabis research, has developed the industry’s first line of fast-acting, 100% water-soluble, truly consistent edible products that deliver a predictable and reliable experience.

arcview market

Hundreds of Marijuana Investors Meet Dozens of Start Ups in Austin, TX May 2-3

AUSTIN, Texas, April 20, 2017 /Weed Wire/ — More than 200 high-net worth investors from around the world, eager to invest in the fastest growing industry in America will gather at AT&T Conference & Education Center for a two day “Shark Tank”-like pitch forum.

Florida Congressman Introduces Legislation to Reschedule Cannabis

Florida Congressman Introduces Legislation to Reschedule Cannabis

On April 6, 2017, United States Rep. Matt Gaetz, R-Fla., announced the introduction of a bill to reschedule cannabis from Schedule I to Schedule III, shifting it from a class of drugs categorized as having no medical benefit to a class of drugs categorized as having known medical benefits paired with low rates of abuse and dependence.

Hebrew University Launches Multidisciplinary Center on Cannabinoid Research

Hebrew University Launches Multidisciplinary Center on Cannabinoid Research

JERUSALEM, April 5, 2017 /Weed Wire/ — The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research.

Researchers Identify Genes That Give Cannabis Its Flavour

VANCOUVER, British Columbia, March 29, 2017 /Weed Wire/ — UBC scientists have scanned the genome of cannabis plants to find the genes responsible for giving various strains their lemony, skunky or earthy flavours, an important step for the budding legal cannabis industry.

Americans for Safe Access Opioid Veterans Senate Committee

Cannabis Patients, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C.

WASHINGTON, March 28, 2017 /Weed Wire/ — Starting on Friday, April 7th and running until Tuesday, April 11th, medical cannabis industry business leaders, medical and legal professionals, advocates, and patients will gather at the Unity 2017 conference in Washington, D.C. to discuss common-sense policies and approaches to safe medical cannabis access and use. With the uncertainty of policies under a new U.S. administration, 2017 will be one of the most important years for medical cannabis policy ever.

How to Profit from the U.S.-U.K. Marijuana “Research Gap”

How to Profit From the U.S. and U.K. Marijuana ‘Research Gap’

Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.

Federal Marijuana Does Not Test Well

Federal Marijuana Does Not Test Well

Marijuana grown by the federal government for research purposes does not have the same quality as the pot from other sources. Until recently, the U.S. federal government had to grow all the marijuana that would be used in scientific research, but researchers have found the government’s pot to be, essentially, irrelevant.

MJIN_MAPS-Logo-Web

Statement on the Adequacy of Marijuana Provided by NIDA for Phase 2 Clinical Trials for PTSD in Veterans

PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).

Enter England: Oxford University Launches Medical Cannabis Research Program

Enter England: Oxford University Launches Medical Cannabis Research Program

Oxford University, one of the oldest and most prestigious universities in the world, recently announced that it is launching a program to research the therapeutic benefits of cannabinoids in the treatment of cancer, inflammatory disease and pain.

Oxford Cannabinoid Technologies

The University of Oxford and Kingsley Capital Partners Announce Ground Breaking Cannabinoid Biomedicine Research Programme

OXFORD, England, March 15, 2017 /Weed Wire/ — Oxford University (“Oxford”) and Kingsley Capital Partners (“Kingsley”) today announce the launch of a pioneering research programme to investigate the role of cannabinoids in biology and medicine.

Enlucem

Enlucem Releases Findings of Calif. Consumer Cannabis Study

SAN FRANCISCO, March 14, 2017 /Weed Wire/ — Enlucem, a strategic brand consultancy currently advising startups in the cannabis space, announced today the results of a detailed consumer study of Californians’ attitudes toward cannabis products.

'Fake weed' linked to more risk-taking than real marijuana

‘Fake Weed’ Linked to More Risk-Taking Than Real Marijuana

Conducted by the Centers for Disease Control and Prevention, this is the first study to explore the association of the use of synthetic cannabinoids in U.S. high school students and health behaviors related to violence, mental health and sexual health.

city council

Bipartisan Vote Carries Medical Marijuana Research Bill to Passage in New Mexico State House

Saturday afternoon, the New Mexico State House voted (41-26) to pass House Bill 155, co-sponsored by Rep. D. Armstrong (D-Albuquerque) and Rep. McCamley (D-Las Cruces) to establish a fund in the state treasury for research related to the production, uses, effects, and efficacy of medical marijuana.

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.

Science and Medicine of Cannabis: Coping With PTSD

Science and Medicine of Cannabis: Coping With PTSD

Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.

Study: 23% of Colorado's Cannabis Workers Lack Health and Safety Training

Study: 23% of Colorado’s Cannabis Workers Lack Health and Safety Training

In mid-February, researchers at Colorado State University and the Center for Health, Work & Environment at the Colorado School of Public Health, published “Work and Well-Being in the Colorado Cannabis Industry.”

Australia-Coat-of-Arms

Office of Drug Control Grants First Cannabis Licence

CANBERRA, Australia, Feb. 20, 2017 /Weed Wire/ — On Friday 17 February 2017, the Office of Drug control issued the very first licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. The licence is a cannabis research licence and has been issued to Cannoperations Pty Ltd, a wholly owned subsidiary of the Australian company Cann Group Limited.

CannMed 2017

CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April

WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.

PTSD Marijuana Study Dispenses MMJ to First Military Veteran

PTSD Marijuana Study Dispenses MMJ to First Military Veteran

On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.

MedMen

Illicit Market Underscores Pent-Up Demand for Legal Cannabis

LOS ANGELES, Jan. 27, 2017 /Weed Wire/ — Despite major strides in legalization at the state level, illicit trade still accounts for nearly 90 percent of U.S. cannabis sales on average, according to a recent report on the state of the cannabis industry in North America.

arcview market

Consumers Spend $53.3B on Legal, Medical & Illicit Marijuana Sales in North America

OAKLAND, Calif., Jan. 17, 2016 /Weed Wire/ — Arcview Market Research, the leading publisher of cannabis market research, released the first ever estimate of the entire North American cannabis market, including legal, medical and illicit marijuana sales.


Page 3 of 812345...Last »
Top